Regenerative Medicine Market - Forecast(2019 - 2024)

Report Code: HCR 0366 Report Format: PDF + Excel (Delivery in 48 Hrs)
Regenerative Medicine Market Overview:

As per the Organ Procurement and Transplantation Network, 36,527 organ transplants were accomplished in the United States in 2018[1]. Regenerative medicines plays a vital role in transplants as it refers to an interdisciplinary field and is a branch of translational research that applies engineering and life science principles to promote regeneration, and can potentially restore diseased and injured tissues as well as whole organs. Apart from organ regeneration, regenerative medicines are effective in cell therapy, gene therapy, and tissue engineering, and are applicable in cardiology, oncology, dermatology, and ophthalmology. Owing to higher prevalence of chronic diseases, genetic diseases, and aging population, causing a higher requirement for organs and biomaterials for tissue regeneration, the regenerative medicine market has escalated to be valued in between $26 billion-$27 billion as of 2018. The analyst of this business intelligence report has tracked this developing marketplace to be progressing economically at a CAGR of 22%-24% during the forecast period 2019-2025.

Regenerative Medicine Market Outlook:

According to Global Burden of Disease, a study by WHO, musculoskeletal conditions are the second highest contributor to global disability. And, Institute for Health Metrics and Evaluation (IHME) has revealed that the total burden of disability increased by 52% between 1990 and 2017.
Gene therapy and tissue engineering in orthopedic surgery endures to assist as the foundation for innovative treatments of innumerable musculoskeletal disorders. Regenerative medicine market is all established to capitalize on the global musculoskeletal disorder rate as it assists in tissue engineering and therapy. Due to such occurrences, orthopedic & musculoskeletal cases dominate the application segment and is flourishing with an application CAGR of 21%-23% going through 2025.

After an acute analysis of the regional aspects of regenerative medicine market, North America has been located as the leading region encapsulating under its terrain around 30%-32% of the global regenerative medicine market demand. The sheer affluence of this region can be attributed to several facts. The United States with its existing modern and cutting-edge healthcare infrastructure is compatible for intricate medical outputs such as stem cell and oncology research augmenting regenerative market. Accelerating frequency of ailments, for instance cancer and diabetes, in the United Sates is positively affecting the market. National Cancer Institute estimated the nationwide expenses for cancer care in the United States in 2017 were $147.3 billion[2].  Similarly 23.1 million folks in the United States are diagnosed with diabetes at a cost of more than $245 billion per year[3].  Awareness among population regarding the available stem cell procedures and therapies effectively curing cancer and diabetes is increasing, which consequence in increasing the demand for the regenerative medicine market.

Regenerative Medicine Market Growth Drivers and Trends:

One of the major drivers of regenerative medicine market is the growing research and developments activities and innovations and funding in biomaterials, nanotechnology, drug delivery, and cell therapies.

The 21st Century Cures Act, approved in December 2016, created room for establishment of Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2017–2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety[4]

Socio-economic context is restricting folks from developing economies to afford organ transplantation. Inadequate stock of organs is instigating serious crime of organ trafficking common in Pakistan, India, and China. This circumstantial setting requires to be disrupted with abrupt response and demands for discovery an alternative source of organ transplantation such as regenerative medicine.

Regenerative Medicine Market Challenges:

Emerging economies with mounting instances of chronic diseases, genetic diseases, and aging population, where there is a higher demand for organs and biomaterials for tissue regeneration have low awareness of developments in regenerative medicine due to low healthcare expenditure.

But however, research and developments with adequate influx of investments and funding are progressing towards economical commercialization of such intricate medical procedures.



Regenerative Medicine Market Players Perspective:

Vertex Pharmaceuticals Incorporated, Medtronic Plc, Allegan Plc, Smith & Nephew Plc, Nuvasive, Inc, Cytori Therapeutics, Inc, Vericel Corporation, BlueRock Therapeutics, Octane Biotech Inc, and Theracell Advanced Biotechnology Ltd are some of the key players functional and effective in the regenerative medicine market.

Vertex Pharmaceuticals Incorporated, revealed on February 12, 2018 that their third medicine SYMDEKO™ got approved by FDA for cystic fibrosis (CF), a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Such developments curate the future revenue for regenerative medicine market.

Regenerative Medicine Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the regenerative medicine market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various researches in regenerative medicine market, and their specific applications in different types of ailments. 

Regenerative Medicine Market Report: Industry Coverage

By Products: Analyzers, Reagents

End Users: Hospitals, Clinical Laboratories, Academics

By Applications: Oncology, Microbiology, Others

The regenerative medicine market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia 

Key Questions Addressed in the Regenerative Medicine Market Report
1. Is the market for regenerative medicine growing? How long will it continue to grow and at what rate? 
2. Which type of diagnostics presents the major growth opportunities? 
3. Is there a possibility for change in the market structure over time?  
4. Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands? 
5. Do the key vendors look for partnerships to expand their businesses with respect to geography or product? 
6. What are the short-term, long-term, and medium-term growth drivers for the market? 
7. What are the short-term, medium-term, and long-term challenges for the market? 
8. What are the short-term, medium-term, and long-term opportunities for the market 
9. Who are the top players/companies of the market? 
10. What are the recent innovations in the market? 
11. How many patents have been filed by the leading players? 
12. What are the types of patents filed by the leading players? 
13. What is our Vision 2030 for Regenerative Medicine Market? 


A few focus points of this Research are given below:

  • Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
  • Provide an overview of the product portfolio, including product planning, development, and positioning
  • Discuss the role of technology companies in partnerships
  • Explore the regional sales activities
  • Analyze the market size and giving the forecast for current and future regenerative medicine during the forecast 2018–2023
  • Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures 

Reference:

[1]https://optn.transplant.hrsa.gov/news/organ-transplants-in-united-states-set-sixth-consecutive-record-in-2018/
[2]https://www.cancer.gov/about-cancer/understanding/statistics
[3]https://www.niddk.nih.gov/health-information/communication-programs/ndep/health-professionals/practice-transformation-physicians-health-care-teams/why-transform/current-burden-diabetes-us
[4]https://www.nih.gov/research-training/medical-research-initiatives/rmi
1. Regenerative Medicine Market — Market Overview
1.1. Definitions and Scope
2. Regenerative Medicine Market — Executive Summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends Segmented by Geography
3. Regenerative Medicine Market — Market Landscape
3.1. Comparative Analysis
3.1.1. Product Benchmarking — Top 10 Companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value Split by Key Companies
3.1.4. Pricing Analysis
4. Regenerative Medicine Market — Startup Companies Scenario
4.1. Key Startup Company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Venture Capital and Funding Scenario
5. Regenerative Medicine Market — Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing Business Index
5.3. Case Studies of Successful Ventures
5.4. Customer Analysis — Key Companies
6. Regenerative Medicine Market — Market Forces
6.1. Drivers
6.2. Constraints & Challenges
6.3. Porter’s Five Force Model
6.3.1. Bargaining Power of Suppliers
6.3.2. Bargaining Power of Customers
6.3.3. Threat of New Entrants
6.3.4. Rivalry Among Existing Players
6.3.5. Threat of Substitutes
7. Regenerative Medicine Market — Strategic Analysis
7.1. Value Chain Analysis
7.2. Opportunities Analysis
7.3. Market Life Cycle
8. Regenerative Medicine Market — By Therapy (Market Size — $Million/$Billion)
8.1. Market Size and Market Share Analysis
8.2. Therapy Segment Analysis
8.2.1. Cell Therapy
8.2.2. Gene Therapy
8.2.3. Tissue Engineering
8.2.4. Others
9. Regenerative Medicine Market — By Product (Market Size — $Million/$Billion)
9.1. Market Size and Market Share Analysis
9.2. Product Segment Analysis
9.2.1. Cell-Based Products
9.2.1.1. Allogeneic Products
9.2.1.2. Autologous Products
9.2.2. Acellular Products
10. Regenerative Medicine Market — By Material (Market Size — $Million/$Billion)
10.1. Market Size and Market Share Analysis
10.2. Material Segment Analysis
10.2.1. Synthetic Material
10.2.1.1. Biodegradable Synthetic Polymers
10.2.1.2. Scaffold
10.2.1.3. Artificial Vascular Graft Materials
10.2.1.4. Hydrogel Materials
10.2.2. Biologically Derived Material
10.2.2.1. Collagen
10.2.2.2. Xenogeneic Material
10.2.3. Genetically Engineered Material
10.2.3.1. Genetically Manipulated Cells
10.2.3.2. 3D Polymer Technology
10.2.3.3. Transgenic
10.2.3.4. Fibroblast
10.2.3.5. Neural Stem Cells
10.2.3.6. Gene-activated Matrices
10.2.4. Pharmaceutical
10.2.4.1. Small Molecules
10.2.4.2. Biologics
11. Regenerative Medicine Market — By Application (Market Size — $Million/$Billion)
11.1. Market Size and Market Share Analysis
11.2. Application Segment Analysis
11.2.1. Orthopedic & Musculoskeletal
11.2.2. Cardiovascular
11.2.3. Oncology
11.2.4. Dermatology
11.2.5. Neurology
11.2.6. Ophthalmology
11.2.7. Hematology & Immunology
11.2.8. Diabetes
11.2.9. Esophagus
11.2.10. Dental
11.2.11. Others
12. Regenerative Medicine Market — By Geography (Market Size — $Million/$Billion)
12.1. Regenerative Medicine Market — North America Segment Research
12.2. North America Market Research (Market Size — $Million/$Billion)
12.2.1. Segment Size and Market Size Analysis
12.2.2. Revenue and Trends
12.2.3. Therapy Analysis
12.2.4. Product Industry Analysis
12.2.5. Material Industry Analysis
12.2.6. Application Analysis
12.2.7. North America Segment Analysis
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Regenerative Medicine Market — South America Segment Research
12.4. South America Market Research (Market Size — $Million/$Billion)
12.4.1. Segment Size and Market Size Analysis
12.4.2. Revenue and Trends
12.4.3. Therapy Analysis
12.4.4. Product Industry Analysis
12.4.5. Material Industry Analysis
12.4.6. Application Analysis
12.4.7. South America Segment Analysis
12.4.7.1. Brazil
12.4.7.2. Chile
12.4.7.3. Argentina
12.4.7.4. Rest of South America
12.5. Regenerative Medicine Market — Europe Segment Research
12.6. Europe Market Research (Market Size — $Million/$Billion)
12.6.1. Segment Size and Market Size Analysis
12.6.2. Revenue and Trends
12.6.3. Therapy Analysis
12.6.4. Product Industry Analysis
12.6.5. Material Industry Analysis
12.6.6. Application Analysis
12.6.7. Europe Segment Analysis
12.6.7.1. U.K.
12.6.7.2. Germany
12.6.7.3. Italy
12.6.7.4. France
12.6.7.5. Russia
12.6.7.6. Spain
12.6.7.7. Rest of Europe
12.7. Regenerative Medicine Market — APAC Segment Research
12.8. Asia Pacific Market Research (Market Size — $Million/$Billion)
12.8.1. Segment Size and Market Size Analysis
12.8.2. Revenue and Trends
12.8.3. Therapy Analysis
12.8.4. Product Industry Analysis
12.8.5. Material Industry Analysis
12.8.6. Application Analysis
12.8.7. APAC Segment Analysis
12.8.7.1. China
12.8.7.2. Australia
12.8.7.3. Japan
12.8.7.4. South Korea
12.8.7.5. India
12.8.7.6. Rest of APAC
12.9. Regenerative Medicine Market — Middle East Segment and Africa Segment Research
12.10. Middle East and Africa Market Research (Market Size — $Million/$Billion)
12.10.1. Segment type Size and Market Size Analysis
12.10.2. Revenue and Trends
12.10.3. Therapy Analysis
12.10.4. Product Industry Analysis
12.10.5. Material Industry Analysis
12.10.6. Application Analysis
12.10.7. Middle East & Africa Segment Analysis
12.10.7.1. Middle East
12.10.7.2. Africa
13. Regenerative Medicine Market — Market Entropy
14. Regenerative Medicine Market — Key Company List by Country Premium
15. Regenerative Medicine Market Company Analysis
15.1. Market Share, Company Revenue, Products, M&A, Developments
15.2. Vertex Pharmaceuticals Inc. (U.S.)
15.3. Medtronic Plc (Ireland)
15.4. NuVasive, Inc. (U.S.)
15.5. Integra LifeSciences  Holdings Corporation (U.S.)
15.6. Smith & Nephew Plc (U.K.)
15.7. Mesoblast Ltd. (Australia)
15.8. Vericel Corporation (U.S.)
15.9. Athersys, Inc. (U.S.)
15.10. Exactech, Inc. (U.S.) 
15.11. Company 10
15.12. Company 11
15.13. Company 12 and more
"*Financials of private companies will be provided on a best-efforts basis"
16. Regenerative Medicine Market — Appendix
16.1. Abbreviations
16.2. Sources
17. Regenerative Medicine Market — Methodology
17.1. Research Methodology
17.1.1. Company Expert Interviews
17.1.2. Industry Databases
17.1.3. Associations
17.1.4. Company News
17.1.5. Company Annual Reports
17.1.6. Application Trends
17.1.7. New Products and Product Database
17.1.8. Company Transcripts
17.1.9. R&D Trends
17.1.10. Key Opinion Leaders Interviews
17.1.11. Supply and Demand Trends
List of Tables
Table 1: Regenerative Medicine Market Overview 2019-2024
Table 2: Regenerative Medicine Market Leader Analysis 2018-2019 (US$)
Table 3: Regenerative Medicine Market Product Analysis 2018-2019 (US$)
Table 4: Regenerative Medicine Market End User Analysis 2018-2019 (US$)
Table 5: Regenerative Medicine Market Patent Analysis 2013-2018* (US$)
Table 6: Regenerative Medicine Market Financial Analysis 2018-2019 (US$)
Table 7: Regenerative Medicine Market Driver Analysis 2018-2019 (US$)
Table 8: Regenerative Medicine Market Challenges Analysis 2018-2019 (US$)
Table 9: Regenerative Medicine Market Constraint Analysis 2018-2019 (US$)
Table 10: Regenerative Medicine Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Regenerative Medicine Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Regenerative Medicine Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Regenerative Medicine Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Regenerative Medicine Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Regenerative Medicine Market Value Chain Analysis 2018-2019 (US$)
Table 16: Regenerative Medicine Market Pricing Analysis 2019-2024 (US$)
Table 17: Regenerative Medicine Market Opportunities Analysis 2019-2024 (US$)
Table 18: Regenerative Medicine Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Regenerative Medicine Market Supplier Analysis 2018-2019 (US$)
Table 20: Regenerative Medicine Market Distributor Analysis 2018-2019 (US$)
Table 21: Regenerative Medicine Market Trend Analysis 2018-2019 (US$)
Table 22: Regenerative Medicine Market Size 2018 (US$)
Table 23: Regenerative Medicine Market Forecast Analysis 2019-2024 (US$)
Table 24: Regenerative Medicine Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 26: Regenerative Medicine Market By Therapy, Revenue & Volume, By Cell Therapy, 2019-2024 ($)
Table 27: Regenerative Medicine Market By Therapy, Revenue & Volume, By Gene Therapy, 2019-2024 ($)
Table 28: Regenerative Medicine Market By Therapy, Revenue & Volume, By Tissue Engineering, 2019-2024 ($)
Table 29: Regenerative Medicine Market By Therapy, Revenue & Volume, By Small Molecules, 2019-2024 ($)
Table 30: Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 31: Regenerative Medicine Market By Product, Revenue & Volume, By Autologous Cell-based Products, 2019-2024 ($)
Table 32: Regenerative Medicine Market By Product, Revenue & Volume, By Allogeneic Cell-based Products, 2019-2024 ($)
Table 33: Regenerative Medicine Market By Product, Revenue & Volume, By Acellular Products, 2019-2024 ($)
Table 34: Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 35: Regenerative Medicine Market By Material, Revenue & Volume, By Synthetic Material, 2019-2024 ($)
Table 36: Regenerative Medicine Market By Material, Revenue & Volume, By Biologically Derived Material, 2019-2024 ($)
Table 37: Regenerative Medicine Market By Material, Revenue & Volume, By Genetically Engineered Material, 2019-2024 ($)
Table 38: Regenerative Medicine Market By Material, Revenue & Volume, By Pharmaceuticals, 2019-2024 ($)
Table 39: Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 40: Regenerative Medicine Market By Application, Revenue & Volume, By Orthopedic & Musculoskeletal Spine, 2019-2024 ($)
Table 41: Regenerative Medicine Market By Application, Revenue & Volume, By Dermatology, 2019-2024 ($)
Table 42: Regenerative Medicine Market By Application, Revenue & Volume, By Cardiovascular, 2019-2024 ($)
Table 43: Regenerative Medicine Market By Application, Revenue & Volume, By Central Nervous System, 2019-2024 ($)
Table 44: Regenerative Medicine Market By Application, Revenue & Volume, By Oncology, 2019-2024 ($)
Table 45: North America Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 46: North America Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 47: North America Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 48: North America Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 49: South america Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 50: South america Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 51: South america Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 52: South america Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 53: Europe Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 54: Europe Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 55: Europe Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 56: Europe Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 57: APAC Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 58: APAC Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 59: APAC Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 60: APAC Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 61: Middle East & Africa Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 62: Middle East & Africa Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 63: Middle East & Africa Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 64: Middle East & Africa Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 65: Russia Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 66: Russia Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 67: Russia Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 68: Russia Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 69: Israel Regenerative Medicine Market, Revenue & Volume, By Therapy, 2019-2024 ($)
Table 70: Israel Regenerative Medicine Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 71: Israel Regenerative Medicine Market, Revenue & Volume, By Material, 2019-2024 ($)
Table 72: Israel Regenerative Medicine Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 73: Top Companies 2018 (US$)Regenerative Medicine Market, Revenue & Volume
Table 74: Product Launch 2018-2019Regenerative Medicine Market, Revenue & Volume
Table 75: Mergers & Acquistions 2018-2019Regenerative Medicine Market, Revenue & Volume

List of Figures

Figure 1: Overview of Regenerative Medicine Market 2019-2024
Figure 2: Market Share Analysis for Regenerative Medicine Market 2018 (US$)
Figure 3: Product Comparison in Regenerative Medicine Market 2018-2019 (US$)
Figure 4: End User Profile for Regenerative Medicine Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Regenerative Medicine Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Regenerative Medicine Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Regenerative Medicine Market 2018-2019
Figure 8: Ecosystem Analysis in Regenerative Medicine Market 2018
Figure 9: Average Selling Price in Regenerative Medicine Market 2019-2024
Figure 10: Top Opportunites in Regenerative Medicine Market 2018-2019
Figure 11: Market Life Cycle Analysis in Regenerative Medicine Market
Figure 12: GlobalBy TherapyRegenerative Medicine Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy ProductRegenerative Medicine Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy MaterialRegenerative Medicine Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy ApplicationRegenerative Medicine Market Revenue, 2019-2024 ($)
Figure 16: Global Regenerative Medicine Market - By Geography
Figure 17: Global Regenerative Medicine Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 18: Global Regenerative Medicine Market CAGR, By Geography, 2019-2024 (%)
Figure 19: North America Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 20: US Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 21: US GDP and Population, 2018-2019 ($)
Figure 22: US GDP – Composition of 2018, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Canada Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 25: Canada GDP and Population, 2018-2019 ($)
Figure 26: Canada GDP – Composition of 2018, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 28: Mexico Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 29: Mexico GDP and Population, 2018-2019 ($)
Figure 30: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 32: South America Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil GDP and Population, 2018-2019 ($)
Figure 35: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Venezuela Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 38: Venezuela GDP and Population, 2018-2019 ($)
Figure 39: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Argentina Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 42: Argentina GDP and Population, 2018-2019 ($)
Figure 43: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Ecuador Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 46: Ecuador GDP and Population, 2018-2019 ($)
Figure 47: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Peru Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 50: Peru GDP and Population, 2018-2019 ($)
Figure 51: Peru GDP – Composition of 2018, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Colombia Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 54: Colombia GDP and Population, 2018-2019 ($)
Figure 55: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Costa Rica Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 58: Costa Rica GDP and Population, 2018-2019 ($)
Figure 59: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 61: Europe Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 62: U.K Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 63: U.K GDP and Population, 2018-2019 ($)
Figure 64: U.K GDP – Composition of 2018, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Germany Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 67: Germany GDP and Population, 2018-2019 ($)
Figure 68: Germany GDP – Composition of 2018, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 70: Italy Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 71: Italy GDP and Population, 2018-2019 ($)
Figure 72: Italy GDP – Composition of 2018, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 74: France Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 75: France GDP and Population, 2018-2019 ($)
Figure 76: France GDP – Composition of 2018, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Netherlands Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 79: Netherlands GDP and Population, 2018-2019 ($)
Figure 80: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Belgium Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 83: Belgium GDP and Population, 2018-2019 ($)
Figure 84: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Spain Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 87: Spain GDP and Population, 2018-2019 ($)
Figure 88: Spain GDP – Composition of 2018, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 90: Denmark Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 91: Denmark GDP and Population, 2018-2019 ($)
Figure 92: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 94: APAC Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 95: China Regenerative Medicine Market Value & Volume, 2019-2024
Figure 96: China GDP and Population, 2018-2019 ($)
Figure 97: China GDP – Composition of 2018, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2018-2019 ($)Regenerative Medicine Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 99: Australia Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 100: Australia GDP and Population, 2018-2019 ($)
Figure 101: Australia GDP – Composition of 2018, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 103: South Korea Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 104: South Korea GDP and Population, 2018-2019 ($)
Figure 105: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 107: India Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 108: India GDP and Population, 2018-2019 ($)
Figure 109: India GDP – Composition of 2018, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Taiwan Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 112: Taiwan GDP and Population, 2018-2019 ($)
Figure 113: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Malaysia Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 116: Malaysia GDP and Population, 2018-2019 ($)
Figure 117: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Hong Kong Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 120: Hong Kong GDP and Population, 2018-2019 ($)
Figure 121: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 123: Middle East & Africa Regenerative Medicine Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 124: Russia Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 125: Russia GDP and Population, 2018-2019 ($)
Figure 126: Russia GDP – Composition of 2018, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Israel Regenerative Medicine Market Value & Volume, 2019-2024 ($)
Figure 129: Israel GDP and Population, 2018-2019 ($)
Figure 130: Israel GDP – Composition of 2018, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 132: Entropy Share, By Strategies, 2018-2019* (%)Regenerative Medicine Market 
Figure 133: Developments, 2018-2019*Regenerative Medicine Market 
Figure 134: Company 1 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 1 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 1 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 2 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 2 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 2 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 3 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 3 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 3 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 4 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 4 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 4 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 5 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 5 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 5 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 6 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 6 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 6 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 7 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 7 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 7 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 8 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 8 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 8 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 9 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 9 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 9 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 10 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 10 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 10 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 11 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 11 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 11 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 12 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 12 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 12 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 13 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 13 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 13 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 14 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 14 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 14 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)
Figure 176: Company 15 Regenerative Medicine Market Net Revenue, By Years, 2018-2019* ($)
Figure 177: Company 15 Regenerative Medicine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 178: Company 15 Regenerative Medicine Market Net Sales Share, By Geography, 2018 (%)